Is Nuclear Cell-Free DNA the "Must-Have" for Risk Stratification in Congenital Heart Surgery? Bouhout I, Goldstone AB. Ann Thorac Surg 2022 Dec 12:S0003-4975(22)01544.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bouhout I, Goldstone AB. Is Nuclear Cell-Free DNA the "Must-Have" for Risk Stratification in Congenital Heart Surgery? Ann Thorac Surg 2022 Dec 12:S0003-4975(22)01544.
PMID: 36521529